This launch aims to elevate chest abnormality detection in Samsung's premium X-ray devices and help clinicians provide a more efficient care path for patients
Boston Imaging,...
Genialis, the RNA-biomarker company, and Debiopharm, a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases,...
Merck to evaluate Variational AI’s Enki™ generative AI platform to design novel and selective small molecules
Variational AI, developer of the Enki™ generative artificial intelligence...
Comprised of leaders from top technology companies and health systems, Suki's board will advance its mission to build the most advanced AI assistant to...
In collaboration with 11 federal agencies, alongside private sector, nonprofit, and philanthropic organizations, the NAIRR pilot is set to offer U.S.-based researchers and educators...
The PPS Analytics platform allows physicians to identify and navigate patients based on personalized pathways and protocols, leading to clinical and economic value creation...
The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws
Researchers at City...
A leading South Korean company providing a total solution for PCR molecular diagnostics, announced its selection of Microsoft as a technology partner for its...
Real-world data to support early patient identification for patients with neurodegenerative and behavioral health diseases.
LANGaware, an innovative leader in digital cognitive and behavioral health...
Enhatch Inc. is excited to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance of a patient specific instrumentation system for Total Knee...